Chiesi UK
Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees
Chiesi UK is a research-driven biopharmaceutical company that develops and markets therapies for chronic and genetic diseases. Its focus spans respiratory health, rare diseases, and specialty care, with medicines delivered to patients in more than 100 countries. The company operates under a shared-value framework as a B Corp and has set a target to achieve Net Zero by 2035. Established in 1999, the UK business is headquartered in Manchester, with a dedicated R&D center in Chippenham and a network of field-based teams. It maintains a sizable workforce across these operations. In 2024 it ranked among the world’s top 25 workplaces, the first European pharmaceutical company to reach that distinction.